Industry research indicates that it takes approximately 10 years on average for an experimental drug to travel from the lab to FDA approval and ultimately patients. And once the product reaches the market, countless factors impact adoption and use – there are potentially thousands of points of contact along the development continuum.
The use of actionable health insights – driven by data and smart AI – helps to identify illness early, allow for proactive intervention, and improve the understanding of disease progression. Technology is the catalyst to break down barriers such as cost and geography that can limit access to health care audiences.
